首页
登录
职称英语
The evidence has gotten much stronger that a substance known as C-reactive p
The evidence has gotten much stronger that a substance known as C-reactive p
游客
2023-08-21
48
管理
问题
The evidence has gotten much stronger that a substance known as C-reactive protein may be every bit as important as cholesterol(胆固醇)in the diagnosis and treatment of heart disease. Back in 2002, a thought-provoking study found that a blood test for C-reactive protein, called CRP, was actually better than the standard cholesterol test at predicting the risk of a heart attack or a stroke. Now two studies published in The New England Journal of Medicine have shown that drugs that reduce the levels of that protein in patients with severe heart disease can slow the progression of atherosclerosis(动脉硬化症)and prevent heart attacks and cardiac-related deaths.
Although the studies came laced with caveats, their cumulative impact suggests that cardiology is in the midst of a revolutionary shift in understanding the causes of heart disease. After years of focusing on the role of cholesterol in clogging arteries, researchers now recognize C-reactive protein, a measure of inflammation(炎症)in artery walls and elsewhere, as a prime risk factor in its own right.
The key study published last week found that heart disease patients who were given high doses of a cholesterol—lowering statin drug also experienced a drop in CRP levels and in heart attacks. Thus the high dose statin packed a double wallop.
These findings apply only to patients already suffering from severe heart disease. A separate clinical trial will seek to determine whether lowering C-reactive protein can reduce heart attacks in healthy patients with normal cholesterol levels but above-average levels of C-reactive protein. Nearly half of all people who suffer heart attacks have normal cholesterol levels, so it is critical to devise tests and treatments to reduce their risk.
Even before the final clinical results are in, it would seem prudent for all overweight couch potatoes who think they are safe because their cholesterol levels are low to get their C-reactive protein levels tested. If their CRP levels are high, they may be spurred to lose weight, exercise and stop smoking to bring down those protein levels. High doses of statins, with their risk of side effects, would presumably be a last resort. [br] The author tells us that______.
选项
A、C-reactive protein is not as important as cholesterol
B、C-reactive protein as a cause of heart disease is still unclear to researchers
C、people had better test C-reactive protein in spite of their low cholesterol level
D、it would be safe for people whose cholesterol levels are normal
答案
C
解析
根据最后一段第一句可知,对于那些胆固醇水平低,从而自认为安全的终日懒散的肥胖者来说,去做一个C-反应蛋白质测试不失为明智之举。由此可知,C)“尽管胆固醇水平低,人们最好还是测试一下C-反应蛋白质”正确。
转载请注明原文地址:https://tihaiku.com/zcyy/2943502.html
相关试题推荐
Thatexperiencesinfluencesubsequentbehaviourisevidenceofanobviousbu
Thatexperiencesinfluencesubsequentbehaviourisevidenceofanobviousbu
Thatexperiencesinfluencesubsequentbehaviourisevidenceofanobviousbu
TheevidencehasgottenmuchstrongerthatasubstanceknownasC-reactivep
TheevidencehasgottenmuchstrongerthatasubstanceknownasC-reactivep
TheevidencehasgottenmuchstrongerthatasubstanceknownasC-reactivep
TheevidencehasgottenmuchstrongerthatasubstanceknownasC-reactivep
Itishardlynecessaryformetocitealltheevidenceofthedepressingsta
Abouttwoweeksago,theU.S.DepartmentofHealth’sSubstanceAbuseandMe
Abouttwoweeksago,theU.S.DepartmentofHealth’sSubstanceAbuseandMe
随机试题
Shouldworkinglonghoursberestricted?Thishasbeenintenselydiscussedf
某患者疑胆管结石行ERCt,检查,4h后剑突下偏左出现持续性疼痛并呕吐。查体:体
在异地发布已经审查批准的药品广告,发布企业须A.持所在地省级药品监督管理部门的审
患者,男,63岁,慢性肾衰竭。近1个月来感食欲下降,伴恶心、腹胀,注意力难以集中
各种运输方式内外部的各个方面的构成和联系,就是( )。 A.运输系统
根据有关法律规定,公安机关有权对犯罪嫌疑人和被告人采取限制人身自由的措施。在公安
弗洛伊德理论的“发展观点”是其()的延伸。单选A.分区观点 B.动力学观点
具有温补气血作用的中成药有A.五子衍宗丸 B.人参归脾丸 C.人参养荣丸
(2019年真题)某企业采用相对指标比较法进行事故统计与分析,下列事故指标中,属
关于建筑意外伤害保险的说法正确的是()。A.《建筑法》规定施工企业必须为从事危险
最新回复
(
0
)